위축성 위염에 대한 반하사심탕과 표준치료 병용요법의 최신 연구 동향
A Review of Recent Clinical Research about Banhasasim-tang Combined with Conventional Therapy on Atrophic Gastritis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: The purpose of this study was to investigate the effect of combined therapy with Banhasasim-tang and conventional treatment for atrophic Gastritis. Methods: The study collected data of clinical studies of combined therapy with Banhasasim-tang and conventional treatment for atrophic gastritis. Electronic databases were used, including PubMed, Cochrane, CNKI, Wanfang, CINII, J-stage, NDSL, and OASIS. The main search terms included such as “Atrophic Gastritis”, “Banhasasim-tang”, “BanXia Xiexin Tang”. This study only included randomized controlled trials (RCTs) that adopted combined therapy with Banhasasim-tang and conventional treatment for atrophic gastritis. Results: A total of 18 RCTs were selected. They all adopted combined therapy with Banhasasim-tang and conventional treatment for atrophic gastritis. In all the studies, the intervention group significantly improved the score of effective rate, and in the 8 studies, Hp negative conversion rate was significantly improved when Banhasasim-tang was taken. Conclusion: Through the analysis of 18 RCTs, we found Banhasasim-tang combined with conventional therapy were more effective in the positive performance of atrophic gastritis than conventional therapy single contribution. However, due to the low quality of the selected studies and the lack of endoscopy, biopsy, follow-up observation, so there is a slight insufficient to prove its conclusion. Therefore, we hope that more systematic and diverse clinical studies will be conducted.
Abstract
Objective: The purpose of this study was to investigate the effect of combined therapy with Banhasasim-tang and conventional treatment for atrophic Gastritis. Methods: The study collected data of clinical studies of combined therapy with Banhasasim-tang and conventional treatment for atrophic gastritis. Electronic databases were used, including PubMed, Cochrane, CNKI, Wanfang, CINII, J-stage, NDSL, and OASIS. The main search terms included such as “Atrophic Gastritis”, “Banhasasim-tang”, “BanXia Xiexin Tang”. This study only included randomized controlled trials (RCTs) that adopted combined therapy with Banhasasim-tang and conventional treatment for atrophic gastritis. Results: A total of 18 RCTs were selected. They all adopted combined therapy with Banhasasim-tang and conventional treatment for atrophic gastritis. In all the studies, the intervention group significantly improved the score of effective rate, and in the 8 studies, Hp negative conversion rate was significantly improved when Banhasasim-tang was taken. Conclusion: Through the analysis of 18 RCTs, we found Banhasasim-tang combined with conventional therapy were more effective in the positive performance of atrophic gastritis than conventional therapy single contribution. However, due to the low quality of the selected studies and the lack of endoscopy, biopsy, follow-up observation, so there is a slight insufficient to prove its conclusion. Therefore, we hope that more systematic and diverse clinical studies will be conducted.
참고문헌 (36)
- Freddie Bray, "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA: A Cancer Journal for Clinicians, 68(6), pp.394~424 (2018), Wiley[DOI]
- Annual report of cancer statistics in Korea in 2016, "Korea Central Cancer Registry, National Cancer Center", Ministry of Health and Welfare, ~ (2018)
- Sipponen P, "Gastric cancer risk in chronic atrophic gastritis : statistical calculations of cross-sectional data", Int J Cancer, 35(2), pp.173~177 (1985)
- Di Gregorio C, "Gastric dysplasia : a follow-up study", Am J Gastroenterol, 88(10), pp.1714~1719 (1993)
- Nayoung Kim, "Prevalence and Risk Factors of Atrophic Gastritis and Intestinal Metaplasia in a Korean Population Without Significant Gastroduodenal Disease", Helicobacter, 13(4), pp.245~255 (2008), Wiley[DOI]
- Annemarie C. de Vries, "Gastric Cancer Risk in Patients With Premalignant Gastric Lesions: A Nationwide Cohort Study in the Netherlands", Gastroenterology, 134(4), pp.945~952 (2008), Elsevier BV[DOI]
- Nayoung Kim, "Helicobacter pylori Infection and Development of Gastric Cancer in Korea", Journal of Clinical Gastroenterology, 42(5), pp.448~454 (2008), Ovid Technologies (Wolters Kluwer Health)[DOI]
- M. Rugge, "Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading", Alimentary Pharmacology and Therapeutics, 16(7), pp.1249~1259 (2002), Wiley[DOI]
- Mauro Cassaro, "Topographic patterns of intestinal metaplasia and gastric cancer", The American Journal of Gastroenterology, 95(6), pp.1431~1438 (2000), Ovid Technologies (Wolters Kluwer Health)[DOI]
- Mariam Abdullahi Adamu, "Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies", European Journal of Epidemiology, 25(7), pp.439~448 (2010), Springer Science and Business Media LLC[DOI]
- Asaka M, "Atrophic changes of gastric mucosa are caused by Helicobacter pylori infection rather than aging : studies in asymptomatic Japanese adults", Helicobacter, 1(1), pp.52~56 (1996)[DOI]
- K AOKI, "Comparison of Prevalence of Chronic Atrophic Gastritis in Japan, China, Tanzania, and the Dominican Republic", Annals of Epidemiology, 15(8), pp.598~606 (2005), Elsevier BV[DOI]
- Fang JY, "Consensus on standard management of choronic gastritis in China", Chinese J Gastroenterology, 18(1), pp.24~36 (2013)
- Moon J, "Shanghanlun Jeonghae", pp.317~319 (2010), Publication Haneui Munhwasa
- Kook YB, "Formula Study", pp.162~164 (2006), Publication Younglimsa
- Takafumi Naito, "Hange-shashin-to Raises Levels of Somatostatin, Motilin, and Gastrin in the Plasma of Healthy Subjects", Biological & Pharmaceutical Bulletin, 25(3), pp.327~331 (2002), Pharmaceutical Society of Japan[DOI]
- Wang XN, "Clinical Observation of Banxia Xiexin Decoction combined with Rebamipide in the Treatment of Chronic Atrophic Gastritis", J North Pharmacy, 16(2), pp.77~ (2019)
- Liu J, "Effect of Modified Banxia Xiexin Decoction in the Treatment of Chronic Atrophic Gastritis", J Practical Traditional Chinese Medicine, 35(7), pp.837~838 (2019)
- Li J, "Evaluation of Modified Banxia Xiexin Decoction Combined with Triple Therapy in the Treatment of Helicobacter Pylori-related Atrophic Gastritis", J Clinical Medical, 6(18), pp.167~170 (2019)
- Wang XM, "Effects of Banxia Xiexin Decoction on Chronic Atrophic Gastritis of Spleen-stomach Damp-heat Type and Serum Inflammatory Index and Immune Function", World Chinese Medicine, 14(2), pp.412~416 (2019)
- Xu H, "Clinical effect of Banxia Xiexin Decoction on chronic atrophic gastritis", Chinese Health Vision, 9, pp.15~ (2019)
- Wang W, "Observation of Clinical Effect of Modified Banxia Xiexin Decoction Combined with Triple Therapy on Helicobacter Pylori-related Atrophic Gastritis", Modern J Integrated Traditional Chinese and Western Medicine, 27(28), pp.3153~3155 (2018)[DOI]
- Wu T, "Effect and safety of Banxia Xiexin Decoction combined with western medicine in the treatment of chronic atrophic gastritis", Chinese and Foreign Medical Research, 16(35), pp.33~34 (2018)[DOI]
- Zhang S, "Analysis of clinical effect of modified Banxia Xiexin decoction in the treatment of chronic atrophic gastritis", Chin J Mod Drug Appl, 12(4), pp.73~74 (2018)
- You H, "Clinical application of Banxia Xiexin Decoction combined with western medicine anti-HP in the treatment of atrophic gastritis", World Latest Medicine Information, 18(96), pp.135~ (2018)[DOI]
- Yang C, "Observation of Clinical effect and safety of Modified Banxia Xiexin Decoction combined with triple therapy in the treatment of H. pylori-related atrophic gastritis", Our Health, 11, pp.42~ (2018)
- Chen W, "Clinical Observation of Banxia Xiexin Tang Combined with Triple Therapy for Chronic Atrophic Gastritis", J New Chinese Medicine, 50(6), pp.93~95 (2018)
- Yang Z, "Clinical Observation of Banxia Xiexin Decoction in Treating Chronic Atrophic Gastritis", Healthmust-Readmagazine, 3, pp.182~ (2018)
- Jiang G, "Observation of clinical effect of Modified Banxia Xiexin Decoction on chronic atrophic gastritis", China Health Care &Nutrition, 28(1), pp.144~145 (2018)
- Zhu T, "Analysis of the clinical effect of Pinellia Heart-Draining Decoction in the treatment of chronic atrophic gastritis", For all Health, 12(5), pp.2~3 (2018)
- Lu X, "Clinical effect of Banxia Xiexin Decoction on chronic atrophic gastritis", Research of Integrated Traditional Chinese and Western Medicine, 9(6), pp.295~296 (2017)[DOI]
- Cui Z, "Clinical Observation of Modified Banxia Xiexin Decoction in the Treatment of Chronic Atrophic Gastritis", Nei Mongol J Traditional Chinese Medicine, 4, pp.32~ (2017)[DOI]
- Xu G, "Clinical Effect of Modified Banxia Xiexin Decoction on Chronic Atrophic Gastritis", China Prac Med, 12(5), pp.143~145 (2017)[DOI]
- Fang J, "Clinical effect observation of Banxia Xiexin decoction in treating chronic atrophic gastritis", Traditional Chinese medicine, 29, pp.107~108 (2017)[DOI]
- Lee S, "The roles of osteopontin on gastric and hepatic carcinogenesis in mouse model", Doctoral, pp.2017
- Kim J, "Atrophy and intestinal metaplasia of the stomach", Korean Society of Gastrointestinal Endoscopy, 50, pp.29~31 (2013)